Back to markets

Johannesburg Stock Exchange

Last update 31 Dec 2025

Aspen Pharmacare Holdings Ltd · APNJ.J

South Africa · Health Care · Pharmaceuticals · ZAR

Price history

11 679 +0.90%

Aspen Pharmacare Holdings Limited is a South Africa-based global specialty and branded multinational pharmaceutical company. The Company focuses on marketing and manufacturing a range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. Its segments include Prescription, Over the counter (OTC), Injectables, Active Pharmaceutical Ingredients (API), Finished Dose Form (FDF) and Heparin. It offers sterile products in injectable form primarily administered in hospitals and also those prescribed and administered by either physicians or in a retail pharmacy environment. Its key brands include Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon and Xylocaine (Injectables). Its OTC segment includes products that do not require prescriptions and are primarily sold in the retail pharmacy and fast-moving consumer goods sectors.

Fundamentals

Metric  (ZAR, M) 2026 2001
Revenue Total Revenue 45
↗

APNJ.J:Key Stats:APNJ.J:Key Stats:11

Page: — · Key Stats|Key Financials¹

Total Revenue: 45019200.5800 → Total Revenue

EBITDA 11
↗

APNJ.J:Key Stats:APNJ.J:Key Stats:11

Page: — · Key Stats|Key Financials¹

EBITDA: 10720913.3800 → EBITDA

EBIT 8
↗

APNJ.J:Key Stats:APNJ.J:Key Stats:11

Page: — · Key Stats|Key Financials¹

EBIT: 8011858.0800 → EBIT

Net income Net Income 6
↗

APNJ.J:Key Stats:APNJ.J:Key Stats:11

Page: — · Key Stats|Key Financials¹

Net Income: 5558266.7100 → Net Income

Operating margin 18%
Net margin 12%